A 38-gene model comprised of key TET2- associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence | BMC Cancer | Full Text

A 38-gene model comprised of key TET2- associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence | BMC Cancer | Full Text

A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence

Early treatment of patients at risk for developing aggressive prostate cancer is able to delay metastasis and reduce mortality; as such, up-front identification of these patients is critical. Several risk clas...

Authors:Shivani Kamdar, Neil E. Fleshner and Bharati Bapat

Citation:BMC Cancer 2020 20:953

Content type:Research article

 

Published on: 2 October 2020

• ViewFull Text
 
• ViewPDF